Cargando…
PReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044571/ http://dx.doi.org/10.1186/1546-0096-11-S2-O19 |
_version_ | 1782319168681410560 |
---|---|
author | Ruperto, N Pistorio, A Knupp Feitosa de Oliveira, S Cuttica, R Ravelli, A Fischbach, M Magnusson, B Avcin, T Brochard, K Corona, F Couillault, G Dressler, F Gerloni, V Sterba, G Zulian, F Apaz, MT Cespedes-Cruz, A Cimaz, R Bracaglia, C Joos, R Quartier, P Russo, R Tardieu, M Wulffraat, N Angioloni, S Martini, A |
author_facet | Ruperto, N Pistorio, A Knupp Feitosa de Oliveira, S Cuttica, R Ravelli, A Fischbach, M Magnusson, B Avcin, T Brochard, K Corona, F Couillault, G Dressler, F Gerloni, V Sterba, G Zulian, F Apaz, MT Cespedes-Cruz, A Cimaz, R Bracaglia, C Joos, R Quartier, P Russo, R Tardieu, M Wulffraat, N Angioloni, S Martini, A |
author_sort | Ruperto, N |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4044571 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40445712014-06-19 PReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate Ruperto, N Pistorio, A Knupp Feitosa de Oliveira, S Cuttica, R Ravelli, A Fischbach, M Magnusson, B Avcin, T Brochard, K Corona, F Couillault, G Dressler, F Gerloni, V Sterba, G Zulian, F Apaz, MT Cespedes-Cruz, A Cimaz, R Bracaglia, C Joos, R Quartier, P Russo, R Tardieu, M Wulffraat, N Angioloni, S Martini, A Pediatr Rheumatol Online J Oral Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4044571/ http://dx.doi.org/10.1186/1546-0096-11-S2-O19 Text en Copyright © 2013 Ruperto et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Oral Presentation Ruperto, N Pistorio, A Knupp Feitosa de Oliveira, S Cuttica, R Ravelli, A Fischbach, M Magnusson, B Avcin, T Brochard, K Corona, F Couillault, G Dressler, F Gerloni, V Sterba, G Zulian, F Apaz, MT Cespedes-Cruz, A Cimaz, R Bracaglia, C Joos, R Quartier, P Russo, R Tardieu, M Wulffraat, N Angioloni, S Martini, A PReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate |
title | PReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate |
title_full | PReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate |
title_fullStr | PReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate |
title_full_unstemmed | PReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate |
title_short | PReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate |
title_sort | pres-final-2184: a randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate |
topic | Oral Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044571/ http://dx.doi.org/10.1186/1546-0096-11-S2-O19 |
work_keys_str_mv | AT ruperton presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT pistorioa presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT knuppfeitosadeoliveiras presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT cutticar presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT ravellia presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT fischbachm presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT magnussonb presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT avcint presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT brochardk presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT coronaf presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT couillaultg presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT dresslerf presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT gerloniv presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT sterbag presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT zulianf presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT apazmt presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT cespedescruza presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT cimazr presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT bracagliac presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT joosr presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT quartierp presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT russor presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT tardieum presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT wulffraatn presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT angiolonis presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate AT martinia presfinal2184arandomizedtrialinnewonsetjuveniledermatomyositisprednisoneversusprednisonepluscyclosporineversusprednisoneplusmethotrexate |